Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria Belgium Czechia France Germany Greece +6
  • Study of Datopotamab Deruxtecan for Patients with Advanced or Metastatic Non-small Cell Lung Cancer with Specific Genetic Changes

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    France The Netherlands Spain
  • Study of ianalumab versus placebo in adults with warm autoimmune hemolytic anemia who failed previous treatment

    Not recruiting

    1 1 1
    France Germany Hungary Italy Romania Spain
  • Study of Ifinatamab Deruxtecan for Patients with Previously Treated Extensive-Stage Small Cell Lung Cancer

    Not recruiting

    1 1
    Investigated drugs:
    France Germany Spain
  • Study of Durbactagene Autoleucel and Drug Combination for Adults with Relapsed and Refractory Multiple Myeloma

    Not recruiting

    1 1 1
    France Germany Greece Italy Spain
  • Study on Long-term Safety and Efficacy of Cipaglucosidase Alfa and Miglustat for Adults with Late-onset Pompe Disease

    Not recruiting

    1 1 1
    Belgium Denmark France Greece Hungary Italy +3
  • Study on the Effect of Human Normal Immunoglobulin on Lung Disease in Patients with Primary Antibody Deficiency

    Not recruiting

    1 1 1 1
    Investigated diseases:
    The Netherlands
  • Study on the Effectiveness of Inavolisib, Atezolizumab, and Entrectinib in Patients with Advanced or Metastatic Solid Tumors

    Not recruiting

    1 1 1
    Belgium Denmark France Germany Italy Poland +2
  • Study on Durvalumab and Tremelimumab for Patients with Advanced Liver Cancer Not Treatable by Surgery

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Germany Italy Spain
  • Study on the Effects of Subcutaneous Human Immunoglobulin (Newnorm) for Patients with Primary Immunodeficiency Diseases

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Hungary Italy Poland Slovakia